Quarterly report pursuant to Section 13 or 15(d)

Business (Details)

v3.23.1
Business (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Feb. 07, 2023
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Debt Instrument [Line Items]        
Cash and cash equivalents   $ 16,687 $ 38,469 $ 13,172
Net loss   (9,955) (22,051)  
Net cash used in operating activities   (10,052) $ (16,067)  
Accumulated deficit   (313,779)   (303,824)
Warrant exercise price (in dollars per share) $ 5.00      
Underwritten Public Offering        
Debt Instrument [Line Items]        
Sale of stock (in shares) 3,770,000      
Net proceeds $ 13,700      
Notes Payable | Horizon & Powerscourt Notes        
Debt Instrument [Line Items]        
Notes payable, outstanding   21,244   $ 21,244
Due in 2023   $ 5,930